Search results
Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin
Zacks via Yahoo Finance· 9 months agoOrchard (ORTX) is set to be acquired by Kyowa Kirin for a consideration of $17 per American...
MEI Pharma, Kyowa Kirin Cull Development Of Blood Cancer Drug Outside Japan, Look For Strategic...
Benzinga via Yahoo Finance· 2 years agoMEI Pharma Inc (NASDAQ: MEIP) and Kyowa Kirin Co Ltd are discontinuing global development of...
Highly Rated Biotech Orchard Therapeutics Scores A Takeover, Shares Nearly Double
Investor's Business Daily· 9 months agoOrchard Therapeutics scored a buyout deal worth up to $478 million from Japan's Kyowa Kirin on...
Why Orchard Therapeutics Stock Is Soaring Today
Motley Fool· 9 months agoShares of the commercial-stage gene therapy company Orchard Therapeutics (NASDAQ: ORTX) were up by a noteworthy 98% on sky-high volume as of 10:13 a.m....
Top 1% Biotech Reata Crashes On A Delay For Its Most Anticipated Drug
Investor's Business Daily· 1 year agoReata Pharmaceuticals scrapped a chronic kidney disease program and announced a delay for its first...
Why Is Reata Pharmaceuticals, Inc. (RETA) Up 6.9% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Reata Pharmaceuticals, Inc. (RETA). Shares...
Ultragenyx (RARE) Sells Portion of Royalty Interest for $500M
Zacks via Yahoo Finance· 2 years agoUltragenyx (RARE) sells 30% of the royalty interest receivable on future North America sales of...
Ultragenyx Sells One-Third Of Future North American Crysvita Royalties For $500M
Benzinga via Yahoo Finance· 2 years agoUltragenyx Pharmaceutical Inc (NASDAQ: RARE) announced the sale of 30% of its royalty interest from...
Ultragenyx's (RARE) Q2 Earnings Miss Estimates, Revenues Up
Zacks via Yahoo Finance· 2 years agoUltragenyx Pharmaceutical Inc. RARE incurred a loss of $2.26 per share in second-quarter 2022, wider...
Feb 8-Japan's Nikkei leaps to 2-week high on tech stocks, yen boost
Reuters via Yahoo Finance· 4 months ago(Corrects analyst's name to Kenji Abe from Shinji Abe) By Kevin Buckland TOKYO (Reuters) -Japan's...